Exacerbation of symptoms due to diltiazem in a patient with lambert-eaton myasthenic myopathic syndrome
dc.contributor.author | Pathirana, K.D. | |
dc.contributor.author | Hidelaratchi, M.D.P. | |
dc.date.accessioned | 2016-01-14T09:41:31Z | |
dc.date.available | 2016-01-14T09:41:31Z | |
dc.date.issued | 2004 | |
dc.identifier.citation | The Ceylon Medical Journal, 49(04)pp.130-131 | |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/20994 | |
dc.publisher | Elsevier. New Delhi | |
dc.subject | Medical Sciences | |
dc.subject | Calcium channel blockers | |
dc.subject | Lambert-eaton myasthenic syndrome | |
dc.subject | Diltiazem | |
dc.subject | Neuromuscular junction disorders | |
dc.subject | Side effects | |
dc.title | Exacerbation of symptoms due to diltiazem in a patient with lambert-eaton myasthenic myopathic syndrome | |
dc.type | Article |